Klein Norman Paul II

CIK 00013846521 companySCOTTSDALE, AZ

SEC Profile

Transactions

Companies

Filings

CIK

0001384652

Recent Transactions

33 trades

Sale
Cellular Biomedicine Group, Inc.
Common Stock
2011-07-07$0.06/sh−800→ 13,561,390 total
Sale
Cellular Biomedicine Group, Inc.
Common Stock
2011-06-30$0.06/sh−8,134→ 13,562,190 total
Sale
Cellular Biomedicine Group, Inc.
Common Stock
2011-06-28$0.06/sh−5,500→ 13,570,324 total
Sale
Cellular Biomedicine Group, Inc.
Common Stock
2011-06-22$0.06/sh−11,366→ 13,575,824 total
Sale
Cellular Biomedicine Group, Inc.
Common Stock
2011-06-17$0.07/sh−25,000→ 13,587,190 total
Sale
Cellular Biomedicine Group, Inc.
Common Stock
2011-06-08$0.07/sh−25,000→ 13,612,190 total
Sale
Cellular Biomedicine Group, Inc.
Common Stock
2011-06-07$0.06/sh−24,000→ 13,637,190 total
Sale
Cellular Biomedicine Group, Inc.
Common Stock
2011-06-06$0.06/sh−1,000→ 13,661,190 total
Sale
Cellular Biomedicine Group, Inc.
Common Stock
2011-06-02$0.07/sh−24,000→ 13,662,190 total
Sale
Cellular Biomedicine Group, Inc.
Common Stock
2011-05-26$0.09/sh−1,000→ 13,686,190 total
Sale
Cellular Biomedicine Group, Inc.
Common Stock
2011-05-25$0.10/sh−25,000→ 13,687,190 total
Sale
Cellular Biomedicine Group, Inc.
Common Stock
2011-05-19$0.10/sh−13,350→ 13,712,190 total
Sale
Cellular Biomedicine Group, Inc.
Common Stock
2011-05-16$0.10/sh−10,000→ 13,725,540 total
Sale
Cellular Biomedicine Group, Inc.
Common Stock
2011-05-13$0.10/sh−1,650→ 13,735,540 total
Sale
Cellular Biomedicine Group, Inc.
Common Stock
2011-05-09$0.10/sh−25,000→ 13,737,190 total
Sale
Cellular Biomedicine Group, Inc.
Common Stock
2011-05-03$0.09/sh−25,000→ 13,762,190 total
Sale
Cellular Biomedicine Group, Inc.
Common Stock
2011-04-28$0.09/sh−24,000→ 13,787,190 total
Sale
Cellular Biomedicine Group, Inc.
Common Stock
2011-04-26$0.09/sh−1,000→ 13,811,190 total
Sale
Cellular Biomedicine Group, Inc.
Common Stock
2011-04-21$0.10/sh−25,000→ 13,812,190 total
Sale
Cellular Biomedicine Group, Inc.
Common Stock
2011-04-20$0.11/sh−50,000→ 13,837,190 total
Sale
Cellular Biomedicine Group, Inc.
Eastbridge Investment Group Corporation
2011-02-11$0.08/sh+1,407,885→ 13,832,196 total
Sale
Cellular Biomedicine Group, Inc.
Common Stock
2011-02-11$0.10/sh−54,995→ 13,887,190 total
Sale
Cellular Biomedicine Group, Inc.
Eastbridge Investment Group Corporation
2010-10-05$0.07/sh−537,115→ 15,240,081 total
Award
Cellular Biomedicine Group, Inc.
Eastbridge Investment Group
2010-05-21$0.11/sh+818,182→ 15,777,196 total
Disposition to Issuer
Cellular Biomedicine Group, Inc.
Eastbridge Investment Group Corporation
2010-05-21$0.10/sh−300,000→ 14,959,014 total
Award
Cellular Biomedicine Group, Inc.
Eastbridge Investment Group Corporation
2010-02-18$0.06/sh+2,541,564→ 15,259,014 total
Award
Cellular Biomedicine Group, Inc.
Eastbridge Investment Group Corporation
2009-08-21$0.02/sh+1,400,000→ 13,641,162 total
Sale
Cellular Biomedicine Group, Inc.
Eastbridge Investment Group Corporation
2009-08-21$0.02/sh−923,712→ 12,717,450 total
Purchase
Cellular Biomedicine Group, Inc.
Eastbridge Investment Group Corporation
2009-05-22$0.01/sh−641,720→ 12,241,162 total
Purchase
Cellular Biomedicine Group, Inc.
Eastbridge Investment Group Corporation
2009-02-25$0.02/sh+500,000→ 13,391,582 total
Purchase
Cellular Biomedicine Group, Inc.
Eastbridge Investment Group
2009-02-25$0.02/sh−508,700→ 12,882,882 total
Purchase
Cellular Biomedicine Group, Inc.
EastBridge Investment Group Corporation
2007-11-06$0.10/sh+100,000→ 9,256,896 total
Purchase
Cellular Biomedicine Group, Inc.
EastBridge Investment Group Corporation
2007-11-05$0.07/sh+2,233,563→ 9,356,896 total

Companies

Cellular Biomedicine Group, Inc.
Director, Corporate Operating Officer

Recent Filings

5
Cellular Biomedicine Group, Inc.
Jun 6, 2013

Address

9971 E. WHITEWING DRIVE

SCOTTSDALE, AZ, 85262

View on SEC.gov